Back to Newsroom
Back to Newsroom

Science & Humans (S&H) Welcomes Esteemed Canadian Endocrinologist & Geneticist Dr. Fady Hannah-Shmouni to Medical Advisory Board

Tuesday, 08 August 2023 06:50 PM

MISSISSAUGA, ON / ACCESSWIRE / August 8, 2023 / Science & Humans (S&H), a health and wellness company focused on managing hormone imbalances to boost healthy aging, is excited to announce the newest addition to their Medical Advisory Board (MAB), Fady Hannah-Shmouni, MD FRCPC.

Science & Humans (S&H), Tuesday, August 8, 2023, Press release picture

Dr. Hannah-Shmouni is an esteemed Canadian endocrinologist as well as geneticist, author, investor, and clinical professor of medicine at the University of British Columbia, who has centered his career around precision medicine in hormones, wellness, and healthy aging. Dr. Hannah-Shmouni's mission and values align perfectly with S&H as the company uses evidence-based practices to transform human life and enable humans to age beautifully.

In this role, Dr. Hannah-Shmouni's expertise will strengthen S&H's gender-neutral practice in treating hormone imbalances. This includes testosterone replacement therapy, growth hormone therapy, bioidentical hormone therapy, and weight loss, as Dr. Hannah-Shmouni's main subject of study - endocrinology - concerns the system that is the source of many of the symptoms S&H treats.

Endocrinology and metabolism plays a pivotal role in hormone health and overall physical and mental wellness. With Dr. Hannah-Shmouni's breadth of knowledge on how hormones affect various body systems, S&H is significantly advancing its expertise in the main function of the business while elevating its care for patients. S&H sees this as an invaluable opportunity to further its medical practices and provide comprehensive care to thousands more Canadians across the country.

"I am honored and beyond excited to join the S&H team, to help advance their digital health platform for meeting the needs of our patients that face significant barriers to accessing hormone health."

Prior to this role, Dr. Hannah-Shmouni served the National Institutes of Health in Bethesda, Maryland as a physician-scientist in endocrinology and genetics in the role of Head of Graduate Medical Education and Associate Program Director of the endocrinology and metabolism fellowship program. His research interests remain on precision medicine in endocrinology, including disorders of the adrenal glands. He has authored over 100 original articles, book chapters, and reviews on endocrine-genetic conditions, and was the founding member and first Editor-in-Chief of the medical journal Endocrine and Metabolic Science (Elsevier). He is the editor of the book, "Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients", and the founder of Healthspan, a precision medicine clinic focused on delivering the most advanced diagnostics in hormone health.

S&H's CEO, Aftab Pashaw, shared that, "Dr. Hannah-Shmouni's extensive experience, exceptional knowledge, and remarkable contributions to the field of endocrinology makes him an invaluable addition to our team." Pashaw continues, "With his guidance, we are confident that we can further optimize our medical services and make a significant difference in the lives of countless Canadians."

About Science & Humans (S&H)

Science & Humans is a first-of-its-kind platform transforming how individuals fulfill their hormone and wellness needs. The company's consumer-first digital platform offers treatments for hormone health, longevity, aging, and sexual wellness. Science & Humans is dedicated to providing accessible options and results for individuals living with hormone imbalances in Canada.

As S&H grows, the future will have a particular focus on treatments for women as the company has recently expanded from being exclusive to men's health to a gender-inclusive practice.

S&H is planning to prove its commitment to women's health through its "Jump for Menopause" campaign, which is, "A message of awareness that spread its wings across North America during Menopause Awareness Month for the over 100 million women experiencing symptoms." This October, S&H will be partnering with a network of skydivers at multiple dropzones to jump with a strong message about menopause. A portion of all funds raised will be going to charity as S&H wants to show its commitment to championing women and catalyzing menopause awareness in North America.

Patient transformation stories and detailed product information is available on the S&H website at, while entities looking to sponsor "Jump for Menopause" are asked to contact S&H directly.

Media Details
Website URL:

Company Name: Science & Humans (S&H)
Email address: [email protected]

SOURCE: Science & Humans (S&H)

Company Update
Back to newsroom
Back to Newsroom
Share by: